Gemcitabine/nab-paclitaxel as second-line therapy following FOLFIRINOX in metastatic/advanced pancreatic cancer - retrospective analysis of response

Journal of Gastrointestinal Oncology

from Gastroenterology via xlomafota13 on Inoreader http://ift.tt/2tjDvwo
via IFTTT